Labetuzumab
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC) .
Product Specifications
CAS Number
219649-07-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
145.1 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1470248-01 0.02 mg (E-Coli)
Recombinant Chlamydia muridarum Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)
Ask
View Details MBS1470248-02 0.02 mg (Yeast)
Recombinant Chlamydia muridarum Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)
Ask
View Details